Beijing Institute of Pharmacology and Toxicology Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2014
NCT02662855
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Beijing Institute of Pharmacology and Toxicology